Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use

Fütterer, 2015, Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging?. A systematic review of the literature, Eur Urol, 68, 1045, 10.1016/j.eururo.2015.01.013

Schoots, 2015, Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis, Eur Urol, 68, 438, 10.1016/j.eururo.2014.11.037

Pokorny, 2014, Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies, Eur Urol, 66, 22, 10.1016/j.eururo.2014.03.002

Panebianco, 2015, Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study, Urol Oncol, 33, 10.1016/j.urolonc.2014.09.013

Delongchamps, 2013, Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies, J Urol, 189, 493, 10.1016/j.juro.2012.08.195

Siddiqui, 2015, Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer, JAMA, 313, 390, 10.1001/jama.2014.17942

Heidenreich, 2011, Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use, Eur Urol, 59, 495, 10.1016/j.eururo.2011.01.013

Dickinson, 2011, Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting, Eur Urol, 59, 477, 10.1016/j.eururo.2010.12.009

Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y

Hamoen, 2015, Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis, Eur Urol, 67, 1112, 10.1016/j.eururo.2014.10.033

Vaché, 2014, Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy, Radiology, 272, 446, 10.1148/radiol.14131584

PI-RADS™ Prostate Imaging and Reporting and Data System: 2015, version 2. American College of Radiology Web site. http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2.pdf.

Wolters, 2011, A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial, J Urol, 185, 121, 10.1016/j.juro.2010.08.082

Radtke, 2015, Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance, J Urol, 193, 87, 10.1016/j.juro.2014.07.098

Renard-Penna, 2015, Prostate Imaging Reporting and Data System and Likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy, Radiology, 275, 458, 10.1148/radiol.14140184

Portalez, 2012, Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients, Eur Urol, 62, 986, 10.1016/j.eururo.2012.06.044

Delongchamps, 2015, Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?, J Urol, 193, 1198, 10.1016/j.juro.2014.11.002

Muller, 2015, Prostate cancer: interobserver agreement and accuracy with the revised Prostate Imaging Reporting and Data System at multiparametric MR imaging, Radiology, 142818

Malyarenko DI, Newitt D, J Wilmes L, et al. Demonstration of nonlinearity bias in the measurement of the apparent diffusion coefficient in multicenter trials. Magn Reson Med. In press. http://dx.doi.org/10.1002/mrm.25754

Padhani, 2009, Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations, Neoplasia, 11, 102, 10.1593/neo.81328

Abd-Alazeez, 2014, The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?, Urol Oncol, 32, 10.1016/j.urolonc.2013.06.007

Abd-Alazeez, 2014, Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard, Prostate Cancer Prostatic Dis, 17, 40, 10.1038/pcan.2013.43

Arumainayagam, 2013, Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard, Radiology, 268, 761, 10.1148/radiol.13120641